Penumbra

Alameda

1,950 Total Employees

Year Founded: 2004

View Website

What's It Like to Work at Penumbra?

Updated on September 08, 2026

This page summarizes recurring themes identified from responses generated by popular LLMs to common candidate questions about Penumbra and has not been reviewed or approved by Penumbra.

What's it like to work at Penumbra?

Strengths in patient‑impact mission, hands‑on learning, and a growing market position are accompanied by challenges around management consistency, bonus expectations, and near‑term acquisition‑related change. Together, these dynamics suggest a meaningful but variable employee experience where fit hinges on role, manager, and comfort with compensation structure and integration transitions.

Key Insight for Candidates

Distinct compensation model: Penumbra generally doesn’t pay annual monetary bonuses. That’s unusual in medtech and can significantly shift total cash versus peers, so candidates should scrutinize base, equity and ESPP, and career-growth upside, especially with acquisition changes potentially reshaping rewards.

Evidence in Action

Patient-First Mission Ethos — The 'help as many people as possible' ethos frames Penumbra’s work on stroke, PE, and DVT therapies. This patient-impact storyline shapes pride, recruiting appeal, and day‑to‑day motivation despite regulatory pace.
No Annual Monetary Bonuses — Compensation language states Penumbra 'does not generally award annual monetary bonuses,' favoring other incentives. Employees weigh base, equity, and benefits more heavily, reshaping expectations and conversations about pay progression.

Positive Themes About Penumbra

Mission & Purpose: Work is framed around life‑saving neurovascular and thrombectomy devices, with many roles emphasizing direct patient impact and a “help as many people as possible” ethos. Feedback suggests a purpose‑driven environment across R&D, manufacturing, and field functions.
Learning & Development: Company materials highlight robust onboarding, promoting from within, and continuous learning programs. Feedback suggests many roles offer solid technical growth and structured training, especially in manufacturing and R&D.
Market Position & Stability: The business is large and expanding, and a definitive agreement to be acquired by Boston Scientific signals strategic value and potential access to broader resources. Feedback suggests growth can translate into opportunities and momentum across functions.

Considerations About Penumbra

Weak Management: Hierarchy, uneven management quality, and limited advancement are cited as trade‑offs alongside strong teammates. Feedback suggests experiences vary significantly by team and manager.
Low Compensation: Compensation practices include not generally awarding annual monetary bonuses, which can be a mismatch for expectations in med‑tech bonus structures. Feedback suggests competitiveness varies by role, level, and location.
Change Fatigue: A pending 2026 acquisition introduces ambiguity around org structures, processes, and priorities. Feedback suggests integration periods bring additional workload and shifting decision rights before benefits fully materialize.

NEW

What does AI tell candidates about your employer brand?

Get your free AI reputation report today.

See AI Report

These insights are generated using AI and may not reflect internal data or verified company information. They are intended solely for general informational purposes and should not be considered a definitive assessment of the company’s reputation. If you are a representative of this company, and would like this page to be removed, you may contact us via this form.